198 related articles for article (PubMed ID: 30324143)
1. Evaluation of serum interleukin-6 levels in hepatocellular carcinoma patients: a systematic review and meta-analysis.
Shakiba E; Ramezani M; Sadeghi M
Clin Exp Hepatol; 2018 Sep; 4(3):182-190. PubMed ID: 30324143
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of serum interleukin-10 levels in hepatocellular carcinoma patients: a systematic review and meta-analysis.
Shakiba E; Ramezani M; Sadeghi M
Clin Exp Hepatol; 2018 Mar; 4(1):35-40. PubMed ID: 29594196
[TBL] [Abstract][Full Text] [Related]
3. A systematic review and meta-analysis of evaluation of serum interleukin 8 levels in hepatocellular carcinoma.
Shakiba E; Sadeghi M; Shakiba M
Clin Exp Hepatol; 2019 May; 5(2):123-128. PubMed ID: 31508492
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Serum Interleukin-6 Levels in the Renal Transplant Recipients: A Systematic Review and Meta-Analysis of Case-Control Studies.
Omrani H; Jasemi SV; Sadeghi M; Golmohamadi S
Open Access Maced J Med Sci; 2019 Jan; 7(1):174-178. PubMed ID: 30740184
[TBL] [Abstract][Full Text] [Related]
6. Association between interleukin 6 polymorphisms (rs1800796, rs1800795, rs2069837, rs17147230, and rs1800797) and hepatocellular carcinoma susceptibility: a meta-analysis.
Aleagha OE; Oltulu P; Sadeghi M
Clin Exp Hepatol; 2020 Dec; 6(4):359-366. PubMed ID: 33511285
[TBL] [Abstract][Full Text] [Related]
7. A systematic review and meta-analysis study of salivary and serum interleukin-8 levels in oral lichen planus.
Mozaffari HR; Sharifi R; Mirbahari S; Montazerian S; Sadeghi M; Rostami S
Postepy Dermatol Alergol; 2018 Dec; 35(6):599-604. PubMed ID: 30618528
[TBL] [Abstract][Full Text] [Related]
8. Sex and regional disparities in incidence of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis.
Yan LJ; Yao SY; Meng GX; Liu KX; Li HC; Ding ZN; Dong ZR; Hong JG; Chen ZQ; Li T
Hepatol Int; 2021 Dec; 15(6):1413-1420. PubMed ID: 34478116
[TBL] [Abstract][Full Text] [Related]
9. Association between Aspartate Aminotransferase-to-Platelet Ratio Index and Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis: A Meta-Analysis of Cohort Study.
Zhang C; Wu J; Xu J; Xu J; Xian J; Xue S; Ye J
Dis Markers; 2019; 2019():2046825. PubMed ID: 31814857
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of interleukin 8 polymorphisms (-251T/A and +781C/T) in patients with hepatocellular carcinoma: a meta-analysis.
Aleagha OE; Moeinzadeh F; Shokouh SFM; Doğan E; Sadeghi M
Clin Exp Hepatol; 2021 Sep; 7(3):278-285. PubMed ID: 34712829
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of associations of interleukin-28B polymorphisms rs8099917 and rs12979860 with development of hepatitis virus-related hepatocellular carcinoma.
Zhang Y; Zhu SL; Chen J; Li LQ
Onco Targets Ther; 2016; 9():3249-57. PubMed ID: 27313470
[TBL] [Abstract][Full Text] [Related]
12. Coinfection of
Madala S; MacDougall K; Surapaneni BK; Park R; Girotra M; Kasi A
J Clin Med Res; 2021 Dec; 13(12):530-540. PubMed ID: 35059071
[TBL] [Abstract][Full Text] [Related]
13. Association of the interleukin-28B gene polymorphism with development of hepatitis virus-related hepatocellular carcinoma and liver cirrhosis: a meta-analysis.
Suo GJ; Zhao ZX
Genet Mol Res; 2013 Sep; 12(3):3708-17. PubMed ID: 24085431
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Serum and Salivary Interleukin-6 and Interleukin-8 Levels in Oral Squamous Cell Carcinoma Patients: Systematic Review and Meta-Analysis.
Rezaei F; Mozaffari HR; Tavasoli J; Zavattaro E; Imani MM; Sadeghi M
J Interferon Cytokine Res; 2019 Dec; 39(12):727-739. PubMed ID: 31314647
[TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies.
Alfaiate D; Clément S; Gomes D; Goossens N; Negro F
J Hepatol; 2020 Sep; 73(3):533-539. PubMed ID: 32151618
[TBL] [Abstract][Full Text] [Related]
16. Presence of diabetes further heightens hepatocellular carcinoma risk in patients with hepatitis B or hepatitis C virus-related cirrhosis: A meta-analysis.
Zang Y; Xu W; Qiu Y; Jiang X; Fan Y
Heliyon; 2023 Aug; 9(8):e18425. PubMed ID: 37520959
[TBL] [Abstract][Full Text] [Related]
17. Association between PNPLA3 rs738409 polymorphisms and risk of hepatocellular carcinoma and its development in patients with cirrhosis: a meta-analysis.
Zhang S; Wu H; Wu X; Lian W; Wang Y; Zhang X; Peng X
Int J Clin Exp Med; 2015; 8(5):6638-49. PubMed ID: 26221201
[TBL] [Abstract][Full Text] [Related]
18. The Performance of GALAD Score for Diagnosing Hepatocellular Carcinoma in Patients with Chronic Liver Diseases: A Systematic Review and Meta-Analysis.
Guan MC; Zhang SY; Ding Q; Li N; Fu TT; Zhang GX; He QQ; Shen F; Yang T; Zhu H
J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769597
[TBL] [Abstract][Full Text] [Related]
19. Systematic review and meta-analysis: Development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis e antigen seroconversion.
Zhou TC; Lai X; Feng MH; Tang Y; Zhang L; Wei J
J Viral Hepat; 2018 Oct; 25(10):1172-1179. PubMed ID: 29741285
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 levels in the serum and saliva of patients with oral lichen planus compared with healthy controls: a meta-analysis study.
Mozaffari HR; Sharifi R; Sadeghi M
Cent Eur J Immunol; 2018; 43(1):103-108. PubMed ID: 29731693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
